Commonwealth Equity Services’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-119,431
Closed -$3.52M 4203
2024
Q3
$3.52M Buy
119,431
+70,980
+146% +$1.63M 0.01% 1471
2024
Q2
$598K Buy
48,451
+3,384
+8% +$71.3K ﹤0.01% 2682
2024
Q1
$914K Buy
45,067
+2,921
+7% +$67.3K ﹤0.01% 2323
2023
Q4
$949K Buy
42,146
+5,008
+13% +$106K ﹤0.01% 2215
2023
Q3
$618K Buy
37,138
+4,755
+15% +$94.2K ﹤0.01% 2419
2023
Q2
$794K Buy
32,383
+2,577
+9% +$62.1K ﹤0.01% 2261
2023
Q1
$718 Buy
29,806
+6,352
+27% +$176K ﹤0.01% 2271
2022
Q4
$692K Buy
23,454
+7,044
+43% +$253K ﹤0.01% 2211
2022
Q3
$686K Buy
16,410
+2,784
+20% +$75.2K ﹤0.01% 2175
2022
Q2
$383K Buy
13,626
+739
+6% +$18.7K ﹤0.01% 2620
2022
Q1
$478K Buy
12,887
+1,067
+9% +$45.2K ﹤0.01% 2563
2021
Q4
$516K Buy
11,820
+1,195
+11% +$62.7K ﹤0.01% 2496
2021
Q3
$659K Sell
10,625
-4,607
-30% -$384K ﹤0.01% 2263
2021
Q2
$1.3M Buy
15,232
+5,584
+58% +$299K ﹤0.01% 1729
2021
Q1
$433K Buy
+9,648
New +$379K ﹤0.01% 2446

Other funds holding FLNA

Commonwealth Equity Services's FLNA Position: Q4 2024 in Review

Commonwealth Equity Services sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 119,431 shares — an estimated $3.52M sold.

Commonwealth Equity Services first reported a position in FLNA in Q1 2021 and held it in 15 quarters. The position peaked at $3.52M in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Commonwealth Equity Services reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 119,431 Filana Therapeutics shares in Q4 2024, an estimated $3.52M.
  • Commonwealth Equity Services first reported a position in Filana Therapeutics in Q1 2021 and held it in 15 quarters.
  • Commonwealth Equity Services's Filana Therapeutics position peaked at $3.52M in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.